Healthcare & Medical Devices Global On demand · 24-48h

Global Joint Rehabilitation Training Device Market Strategic Research Report

Global Joint Rehabilitation Training Device Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Joint Rehabilitation Training Device Market
$1.33B2025
10%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Upper Limb Joints, Lower Limb Joints, whole Body Joints

By Application: Rehabilitation Center, Hospital, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: DJO (Chattanooga), Hocoma, Bioness, Hasomed, Rehametrics, Ekso Bionics, Cyberdyne, Tyromotion, Motorika, Myomo, Bionik, ReWalk Robotics, Xiangyu Medical, Qianjing Rehabilitation, Fourier Intelligence, Siyi Intelligent, Shenzhen Maibu Robotics, Guilin Yikang Electronic Technology, Jizhi Medical, Jingshi Brain Power Technology, Weisi Medical, Xinnuo Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 153 pages
Market size 2025
$1.33B
Billion USD
Forecast CAGR
10%
2025-2032
Forecast 2032
$2.6B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Joint Rehabilitation Training Device market size is predicted to grow from US$ 1,335 million in 2025 to US$ 2,569 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032.

A joint rehabilitation training device is a medical or therapeutic instrument designed to assist patients in recovering joint function through passive, active, or assisted movement training. These devices are commonly used in physical therapy and rehabilitation settings to help patients restore range of motion, muscle strength, and joint flexibility following injuries, surgeries, or conditions such as arthritis and neurological disorders. Joint rehabilitation training devices can be applied to various joints including the knee, shoulder, elbow, wrist, ankle, and hand, and often feature adjustable movement angles, speeds, and resistance levels to accommodate different stages of recovery. The global average selling price for joint rehabilitation training devices is approximately US$450 per unit. The average sales volume in the base year is estimated at 3,033.3k units. The industry average gross margin is approximately 40%, with typical ranges between 30% and 50%, reflecting the diversity of products from basic continuous passive motion (CPM) devices to advanced robotic rehabilitation systems. The upstream segment includes manufacturers of motors, sensors, control systems, aluminum alloys, high-strength plastics, carbon fiber, and other precision components. The midstream segment comprises device manufacturers that design, assemble, and certify complete joint rehabilitation training systems. The downstream segment encompasses hospitals, rehabilitation centers, physical therapy clinics, nursing homes, and home healthcare settings where these devices are used for patient recovery.

The joint rehabilitation training device market is experiencing robust expansion driven by multiple converging factors. The aging global population is a primary driver, as age-related conditions such as osteoarthritis, stroke, and neurodegenerative diseases increasingly require rehabilitation interventions. The growing prevalence of chronic conditions requiring rehabilitation, combined with the persistent shortage of human therapists, has created significant demand for automated and semi-automated training devices that can deliver consistent, repeatable therapy. Technological advancements are fundamentally reshaping the product landscape. The integration of artificial intelligence, haptics, virtual reality, and advanced sensor technologies is enhancing device efficacy and user engagement, enabling personalized rehabilitation programs that adapt to individual patient progress. The shift from traditional single-joint CPM devices to multi-joint robotic systems with intelligent control represents a paradigm evolution in rehabilitation practice. The market is witnessing increasing adoption of portable and home-use devices, driven by the growing emphasis on home healthcare and the desire to reduce hospital readmissions and overall healthcare costs. Lightweight materials and modular designs are improving device portability and functional expandability, making these devices suitable for hospital, community, and home settings. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rapid urbanization, rising healthcare expenditure, and a large burden of undiagnosed rehabilitation needs. Government initiatives promoting independent living and favorable reimbursement policies for rehabilitation services are further propelling market dynamics. As the global burden of musculoskeletal and neurological disorders continues to rise and technological innovation accelerates, the joint rehabilitation training device market is positioned for sustained growth across both clinical and home-based care settings.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Joint Rehabilitation Training Device market?

What factors are driving Joint Rehabilitation Training Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Joint Rehabilitation Training Device market opportunities vary by end market size?

How does Joint Rehabilitation Training Device break out by Type, by Application?

This report presents a comprehensive overview of the global Joint Rehabilitation Training Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Upper Limb Joints
  • Lower Limb Joints
  • whole Body Joints

Segment by Mobility

  • Fixed / Stationary Devices
  • Portable / Mobile Devices

Segment by Training Mode

  • Passive Training Devices (CPM)
  • Active Training Devices
  • Active-Assisted Training Devices

Segment by Application

  • Rehabilitation Center
  • Hospital
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Joint Rehabilitation Training Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Rehabilitation Center, Hospital, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Joint Rehabilitation Training Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.33B
2025
Forecast
$2.6B
2032
CAGR
10%
2025–2032
Области
5
global
Key companies
DJO (Chattanooga)HocomaBionessHasomedRehametricsEkso BionicsCyberdyneTyromotion
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Upper Limb JointsLower Limb Jointswhole Body Joints
By Application
Rehabilitation CenterHospitalOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Upper Limb Joints
  • 3.1.3 Lower Limb Joints
  • 3.1.4 whole Body Joints
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Rehabilitation Center
  • 4.1.3 Hospital
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 DJO (Chattanooga)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Hocoma
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Bioness
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hasomed
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Rehametrics
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Ekso Bionics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cyberdyne
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Tyromotion
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Motorika
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Myomo
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Bionik
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 ReWalk Robotics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Xiangyu Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Qianjing Rehabilitation
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Fourier Intelligence
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Siyi Intelligent
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shenzhen Maibu Robotics
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Guilin Yikang Electronic Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Jizhi Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Jingshi Brain Power Technology
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Weisi Medical
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Xinnuo Medical
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Joint Rehabilitation Training Device market?
The global Joint Rehabilitation Training Device market is estimated at US$ 1.33 billion in 2025 (base year) and is projected to reach US$ 2.57 billion by 2032.
How fast is the Joint Rehabilitation Training Device market expected to grow?
The market is expected to grow at a CAGR of 10.0% from 2026 to 2032, expanding from US$ 1.33 billion in 2025 to US$ 2.57 billion in 2032, roughly 1.9 times its base-year value.
What does the Joint Rehabilitation Training Device market cover?
A joint rehabilitation training device is a medical or therapeutic instrument designed to assist patients in recovering joint function through passive, active, or assisted movement training. These devices are commonly used in physical therapy and rehabilitation settings to help patients restore range of motion, muscle strength, and joint flexibility following injuries, surgeries, or conditions such as arthritis and neurological disorders.
How is the Joint Rehabilitation Training Device market segmented by type?
By type, the market is segmented into Upper Limb Joints, Lower Limb Joints and whole Body Joints.
What are the key applications of Joint Rehabilitation Training Device?
Key applications covered include Rehabilitation Center, Hospital and Other.
Which companies are profiled in the Joint Rehabilitation Training Device market report?
Key players profiled include DJO (Chattanooga), Hocoma, Bioness, Hasomed, Rehametrics, Ekso Bionics, Cyberdyne and Tyromotion, among 22 companies covered in total.
What geographies does the Joint Rehabilitation Training Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Joint Rehabilitation Training Device?
The joint rehabilitation training device market is experiencing robust expansion driven by multiple converging factors.
Who should buy the Joint Rehabilitation Training Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Rehabilitation Center, Hospital and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Joint Rehabilitation Training Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.